China Pharma Holdings (CPHI) Work In Process (2017 - 2024)
China Pharma Holdings' Work In Process was $334,430 in Q3 2024, down 50.6% from $676,885 a year earlier but up 283.0% from the prior quarter.
Powered by 
Analysis
China Pharma Holdings (CPHI) Work In Process (2017 - 2024) Analysis & Trends
At the end of FY2023, Work In Process at China Pharma Holdings came in at $413,597, down 25.8% from FY2022.
- Work In Process shows a five-year compound annual growth rate of -3.5% (FY2018 to FY2023).
- In earlier years, Work In Process was $557,146 in FY2022 (unchanged), $557,146 in FY2021 (-16.0%), $662,999 in FY2020 (+111.0%) and $314,231 in FY2019 (-36.4%).
- Quarterly Work In Process has moved between $87,308 (Q2 2024) and $676,885 (Q3 2023) over five years.
- Compared with a year earlier, Work In Process has declined for four straight quarters, with an average decline of 23.4% over the last seven quarters.
- The best year-over-year quarter for Work In Process over five years was Q4 2020 (growth of 111.0%); the worst was Q2 2024 (a decline of 76.1%).
- Per Business Quant data, CPHI's Work In Process in the three quarters before Q3 2024 was $87,308 (Q2 2024), $242,726 (Q1 2024) and $413,597 (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | China Pharma Holdings | 29.58 Mn | 28.46 Mn | 83,566.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 334,430.00 |
| Jun 30, 2024 | 87,308.00 |
| Mar 31, 2024 | 242,726.00 |
| Dec 31, 2023 | 413,597.00 |
| Sep 30, 2023 | 676,885.00 |
| Jun 30, 2023 | 364,913.00 |
| Mar 31, 2023 | 319,059.00 |
| Dec 31, 2022 | 557,146.00 |
| Sep 30, 2022 | 615,020.00 |
| Jun 30, 2022 | 356,702.00 |
| Dec 31, 2021 | 557,146.00 |
| Sep 30, 2021 | 442,022.00 |
| Jun 30, 2021 | 461,293.00 |
| Mar 31, 2021 | 341,269.00 |
| Dec 31, 2020 | 662,999.00 |
| Sep 30, 2020 | 433,389.00 |
| Jun 30, 2020 | 644,174.00 |
| Mar 31, 2020 | 256,151.00 |
| Dec 31, 2019 | 314,231.00 |
| Sep 30, 2019 | 382,900.00 |
API Access
China Pharma Holdings Work In Process API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=work-in-process&ticker=CPHI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "work-in-process", "ticker": "CPHI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=work-in-process&ticker=CPHI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();